Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Insulinoma 2Nesidioblastosis 1

Interventions

Cisplatin 3205Cyclophosphamide 3200Carboplatin 2979Radiotherapy 2790Paclitaxel 2720Gemcitabine 2573pembrolizumab 2388Bevacizumab 2210Docetaxel 2200Fluorouracil 1851Capecitabine 1834Oxaliplatin 1742Dexamethasone 1606Nivolumab 1581Doxorubicin 1503Rituximab 1489Magnetic Resonance Spectroscopy 1391Etoposide 1346Irinotecan 1248Leucovorin 1227Drug Therapy 1205Cytarabine 1131Pemetrexed 1078fludarabine 1065Specimen Handling 1021Vincristine 966Trastuzumab 946Cetuximab 945Prednisone 943Lenalidomide 938

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
68Ga-NOTA-exendin-4 × Clear all
NCT04979611 2023-09-21

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

First Affiliated Hospital of Fujian Medical University

Phase 1 Unknown
60 enrolled
Endocrine

Insulinoma

NCT02560376 2015-09-25

68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
Endocrine

Insulinoma, Nesidioblastosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡